Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
BINEX Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩12,300.00 |
52 Week High | ₩18,480.00 |
52 Week Low | ₩7,240.00 |
Beta | 0.47 |
1 Month Change | -8.41% |
3 Month Change | 13.78% |
1 Year Change | 13.36% |
3 Year Change | -45.58% |
5 Year Change | 14.95% |
Change since IPO | 547.37% |
Recent News & Updates
BINEX Co., Ltd.'s (KOSDAQ:053030) 30% Share Price Plunge Could Signal Some Risk
Apr 17We Think That There Are More Issues For BINEX (KOSDAQ:053030) Than Just Sluggish Earnings
Mar 22BINEX Co., Ltd.'s (KOSDAQ:053030) Shares Climb 37% But Its Business Is Yet to Catch Up
Feb 26Recent updates
BINEX Co., Ltd.'s (KOSDAQ:053030) 30% Share Price Plunge Could Signal Some Risk
Apr 17We Think That There Are More Issues For BINEX (KOSDAQ:053030) Than Just Sluggish Earnings
Mar 22BINEX Co., Ltd.'s (KOSDAQ:053030) Shares Climb 37% But Its Business Is Yet to Catch Up
Feb 26Does BINEX (KOSDAQ:053030) Have A Healthy Balance Sheet?
Mar 18If You Had Bought BINEX (KOSDAQ:053030) Stock A Year Ago, You Could Pocket A 253% Gain Today
Jan 28Are BINEX Co., Ltd.'s (KOSDAQ:053030) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
Dec 24Shareholder Returns
A053030 | KR Pharmaceuticals | KR Market | |
---|---|---|---|
7D | -14.9% | -1.4% | -1.7% |
1Y | 13.4% | 2.7% | 0.6% |
Return vs Industry: A053030 exceeded the KR Pharmaceuticals industry which returned 2.7% over the past year.
Return vs Market: A053030 exceeded the KR Market which returned 0.6% over the past year.
Price Volatility
A053030 volatility | |
---|---|
A053030 Average Weekly Movement | 14.7% |
Pharmaceuticals Industry Average Movement | 4.2% |
Market Average Movement | 5.1% |
10% most volatile stocks in KR Market | 11.3% |
10% least volatile stocks in KR Market | 2.3% |
Stable Share Price: A053030's share price has been volatile over the past 3 months.
Volatility Over Time: A053030's weekly volatility has increased from 9% to 15% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1957 | 570 | Hyuk-Jong Lee | www.bi-nex.co.kr |
BINEX Co., Ltd. operates as a pharmaceutical company in South Korea. The company’s products portfolio comprises bisroot products; GI tract and antispasmodic, and antiulcer agents; NSAIDs; cardiovascular and urology products; hepatic protectors; ointments and creams; ophthalmic solutions; CNS agents; digestive products; constipation and blood circulation products; antibiotic and antifungal agents; cough and cold remedy products; vitamins and nutrients; antihistamine products; antivertigo products; and OTC products. BINEX Co., Ltd.
BINEX Co., Ltd. Fundamentals Summary
A053030 fundamental statistics | |
---|---|
Market cap | ₩380.37b |
Earnings (TTM) | -₩12.17b |
Revenue (TTM) | ₩136.33b |
2.8x
P/S Ratio-31.3x
P/E RatioIs A053030 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A053030 income statement (TTM) | |
---|---|
Revenue | ₩136.33b |
Cost of Revenue | ₩100.23b |
Gross Profit | ₩36.11b |
Other Expenses | ₩48.27b |
Earnings | -₩12.17b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -393.38 |
Gross Margin | 26.49% |
Net Profit Margin | -8.92% |
Debt/Equity Ratio | 29.2% |
How did A053030 perform over the long term?
See historical performance and comparison